The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Epidemiology and risk factors for invasive candidiasis
Open accessAbstract
The number of immunosuppressive patients has increased significantly in recent years. These patients are at risk for opportunistic infections, especially fungal infections. Candidiasis is one of the most frequent fungal infections determined in these immunosuppressive patients and its epidemiology has changed over the last two decades. Recently, new antifungal agents and new therapy strategies such as antifungal prophylaxis, secondary prophylaxis, and preemptive therapy have come into use. These changes resulted in the alteration of Candida species causing invasive infections. The incidence of Candida albicans was decreased in many countries, especially among patients with immunosuppressive disorders, while the incidence of species other than C. albicans was increased. In this review, incidence, risk factors, and species distribution of invasive candidiasis are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Its prevalence varies with the geographic area [2,3,4].”
From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [3]
In the citing paper
“Recent epidemiological surveys have shown a decrease in the frequency of C. albicans and an increased prevalence of non-albicans Candida [3,5,6].”
From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cisterna, R., Ezpeleta, G., Tellería, O., Guinea, J., Regueiro, B. J., Garcia-Rodríguez, J., & Esperalba, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00920-10 · Cited by 72
RetractedWisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A. K., Patel, J. B., Srinivasan, A., Kallen, A. J., Limbago, B. M., Fridkin, S. K., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,593
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
(2006) · PubMed · Cited by 906
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601
Flagged first, then by citations
Research works printed but not linked: 2
- [7]Lewis RE Overview of the changing epidemiology of candidemia Curr Med Res Opin 2009 25 7 1732 1740 19519284
- [48]Yapar N Akan M Avkan-Oguz V Ergon M Hancer M Doluca-Yucesoy M Risk factors and the incidence of candidemia in the intensive care unit: A 5-year cross-sectional study Proceedings of Twentieth European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) April 10–14, 2010 Vienna, Austria Wiley-Blackwell 2010
Cited by
Sorted by citations
Candida albicans—The Virulence Factors and Clinical Manifestations of Infection
Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & Škrlec, I. (2021) · Journal of Fungi · doi:10.3390/jof7020079 · Cited by 794
“Candida albicans is the most typical cause of candidiasis, although many Candida species other than albicans have been isolated in recent years [105,145].”
BackgroundCandida Biofilms: Threats, Challenges, and Promising Strategies
Cavalheiro, M., & Teixeira, M. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00028 · Cited by 690
Mammalian lipoxygenases and their biological relevance
Kühn, H., Banthiya, S., & van Leyen, K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.002 · Cited by 644
Antifungal resistance: current trends and future strategies to combat
Wiederhold, N. P. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s124918 · Cited by 492
The Still Underestimated Problem of Fungal Diseases Worldwide
Almeida, F. B. D. R., Rodrigues, M. L., & Coelho, C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00214 · Cited by 452
Metadata
- Authors
- Yapar, N.
- Affiliations
- Dokuz Eylül University (TR)
- Corresponding author
- Yapar, Nur
- ORCID
- Yapar, Nur
- Venue
- Therapeutics and Clinical Risk Management
- Publisher
- Informa UK Limited
- Published
- 2014-02
- Volume
- 10
- Pages
- 95
- ISSN
- 1176-6336 (ISSN-L)
- 1178-203X
- PMC
- PMC3928396
- OpenAlex
- W2149946566
- Cited by
- 610
- References
- 70
- Citations by year
- 2026: 13 · 2025: 29 · 2024: 42 · 2023: 39 · 2022: 48 · 2021: 69 · 2020: 93 · 2019: 74 · 2018: 60 · 2017: 54 · 2016: 44 · 2015: 32 · 2014: 11
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Therapeutics and Clinical Risk Management (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- invasive candidiasis, Candida albicans, non-albicans Candida, immunosuppression, opportunistic fungal infection, risk factors, epidemiology, antifungal prophylaxis, secondary prophylaxis, preemptive antifungal therapy, species distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
